Singular Genomics Sys Q2 2024 GAAP EPS $(8.57) Beats $(8.95) Estimate, Sales $737.00K Beat $400.00K Estimate
Portfolio Pulse from Benzinga Newsdesk
Singular Genomics Sys (NASDAQ:OMIC) reported Q2 2024 GAAP EPS of $(8.57), beating the $(8.95) estimate. Sales were $737K, surpassing the $400K estimate and showing a 45.94% increase from the same period last year.
August 13, 2024 | 8:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Singular Genomics Sys reported better-than-expected Q2 2024 results with GAAP EPS of $(8.57) beating estimates and sales of $737K surpassing expectations, showing significant year-over-year growth.
The better-than-expected earnings and significant sales growth indicate strong performance, likely leading to positive short-term price movement for OMIC.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100